Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Carolina Clinical Triasl Inc
mi
from
Charleston, SC
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Carolina Clinical Triasl Inc
mi
from
Charleston, SC
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Community Clinical Research
mi
from
Austin, TX
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Community Clinical Research
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
InSite Clinical Research LLC
mi
from
DeSoto, TX
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
InSite Clinical Research LLC
mi
from
DeSoto, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Pillar Clinical Research, LLC
mi
from
Richardson, TX
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Pillar Clinical Research, LLC
mi
from
Richardson, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Regional Clinical Hospital n.a I.I. Mechnicov
mi
from
Dnipro,
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia
Multicenter, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Regional Clinical Hospital n.a I.I. Mechnicov
mi
from
Dnipro,
Click here to add this to my saved trials
Creating Live Interactions to Mitigate Barriers
Creating Live Interactions to Mitigate Barriers (CLIMB): A Mobile Intervention to Improve Social Functioning in People With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Posit Science Corporation
mi
from
San Francisco, CA
Creating Live Interactions to Mitigate Barriers
Creating Live Interactions to Mitigate Barriers (CLIMB): A Mobile Intervention to Improve Social Functioning in People With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Posit Science Corporation
mi
from
San Francisco, CA
Click here to add this to my saved trials
Functional Neuroimaging Effects of Cognitive Remediation Training
Functional Neuroimaging Effects of Cognitive Remediation Training
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Functional Neuroimaging Effects of Cognitive Remediation Training
Functional Neuroimaging Effects of Cognitive Remediation Training
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia
E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia
E-cigarettes to Promote Smoking Reduction Among Individuals With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
OnTrackNY With the Option of Social Network Meetings
OnTrackNY With the Option of Social Network Meetings
Status: Enrolling
Updated:  12/31/1969
MHA of Westchester
mi
from
Yonkers, NY
OnTrackNY With the Option of Social Network Meetings
OnTrackNY With the Option of Social Network Meetings
Status: Enrolling
Updated: 12/31/1969
MHA of Westchester
mi
from
Yonkers, NY
Click here to add this to my saved trials
Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007).
A Multiple-dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and QTc Effect of MK-8189 in Participants With Schizophrenia and Healthy Participants.
Status: Enrolling
Updated:  12/31/1969
California Clinical Trials
mi
from
Glendale, CA
A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007).
A Multiple-dose Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and QTc Effect of MK-8189 in Participants With Schizophrenia and Healthy Participants.
Status: Enrolling
Updated: 12/31/1969
California Clinical Trials
mi
from
Glendale, CA
Click here to add this to my saved trials
Comparative Bioavailability of Risperidone
An Open-Label, One-Sequence Study to Evaluate the Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM® and Oral Risperidone
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Comparative Bioavailability of Risperidone
An Open-Label, One-Sequence Study to Evaluate the Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM® and Oral Risperidone
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Comparative Bioavailability of Risperidone
An Open-Label, One-Sequence Study to Evaluate the Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM® and Oral Risperidone
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Comparative Bioavailability of Risperidone
An Open-Label, One-Sequence Study to Evaluate the Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM® and Oral Risperidone
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia
A Randomized, Double Blind, Placebo Controlled, Single Ascending Dose Study With Lurasidone Injectable Suspension to Evaluate Safety, Tolerability and Pharmacokinetics in Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Dr David Walling
mi
from
Long Beach, CA
A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia
A Randomized, Double Blind, Placebo Controlled, Single Ascending Dose Study With Lurasidone Injectable Suspension to Evaluate Safety, Tolerability and Pharmacokinetics in Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Dr David Walling
mi
from
Long Beach, CA
Click here to add this to my saved trials
Multi-component Intervention for Diabetes in Adults With Serious Mental Illness
Multi-component Intervention for Diabetes in Adults With Serious Mental Illness (MIDAS)
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego Division of Geriatric Psychiatry
mi
from
La Jolla, CA
Multi-component Intervention for Diabetes in Adults With Serious Mental Illness
Multi-component Intervention for Diabetes in Adults With Serious Mental Illness (MIDAS)
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego Division of Geriatric Psychiatry
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Study to Evaluate Efficacy, Tolerability, Pharmacodynamic and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adults With Schizophrenia
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate Pharmacodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CBH Health, LLC
mi
from
Gaithersburg, MD
A Study to Evaluate Efficacy, Tolerability, Pharmacodynamic and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adults With Schizophrenia
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate Pharmacodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CBH Health, LLC
mi
from
Gaithersburg, MD
Click here to add this to my saved trials
A Study to Evaluate Efficacy, Tolerability, Pharmacodynamic and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adults With Schizophrenia
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate Pharmacodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Kings College London
mi
from
London,
A Study to Evaluate Efficacy, Tolerability, Pharmacodynamic and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adults With Schizophrenia
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate Pharmacodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of TAK-831 in Adult Subjects With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Kings College London
mi
from
London,
Click here to add this to my saved trials
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Siyan Clinical Research
mi
from
Santa Rosa, CA
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Siyan Clinical Research
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Psychiatric Addiction Curative/PACT Atlanta LLC
mi
from
Decatur, GA
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Psychiatric Addiction Curative/PACT Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Kolade Research Institute
mi
from
Las Vegas, NV
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Kolade Research Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Signature Research Associates, Inc.
mi
from
Fairlawn, OH
A Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Signature Research Associates, Inc.
mi
from
Fairlawn, OH
Click here to add this to my saved trials
Virtual Reality Training for Social Skills in Schizophrenia
Physiology-based Virtual Reality Training for Social Skills in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Virtual Reality Training for Social Skills in Schizophrenia
Physiology-based Virtual Reality Training for Social Skills in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States
PET Imaging of Glial Activation in Psychotic Disease States
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Positron Emission Tomography (PET) Imaging of Glial Activation in Psychotic Disease States
PET Imaging of Glial Activation in Psychotic Disease States
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Brain Imaging, Attention, and Auditory Processing in Schizophrenia
Predictive Coding Abnormalities in Psychosis: EEG and fMRI
Status: Enrolling
Updated:  12/31/1969
San Francisco VA Medical Center
mi
from
San Francisco, CA
Brain Imaging, Attention, and Auditory Processing in Schizophrenia
Predictive Coding Abnormalities in Psychosis: EEG and fMRI
Status: Enrolling
Updated: 12/31/1969
San Francisco VA Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression
Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and fMRI Studies of Schizophrenia and Depression
Status: Enrolling
Updated:  12/31/1969
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and Functional Magnetic Resonance Imaging (fMRI) Studies of Schizophrenia and Depression
Rescuing the Ruminating Brain: Identifying Biomarkers of Rumination and Mindfulness Through Concurrent EEG and fMRI Studies of Schizophrenia and Depression
Status: Enrolling
Updated: 12/31/1969
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cognitive Behavioral Therapy for Paranoia in Schizophrenia
Cognitive Behavioral Therapy for Paranoia in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Cognitive Behavioral Therapy for Paranoia in Schizophrenia
Cognitive Behavioral Therapy for Paranoia in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Tolerability of Risperidone Implants
A One Year, Open-label, Study to Evaluate the Safety and Tolerability of Risperidone Implants as a Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Safety and Tolerability of Risperidone Implants
A One Year, Open-label, Study to Evaluate the Safety and Tolerability of Risperidone Implants as a Maintenance Treatment in Patients With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Clinical Trial of Dipyridamole in Schizophrenia
Clinical Trial of Dipyridamole in Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Clinical Trial of Dipyridamole in Schizophrenia
Clinical Trial of Dipyridamole in Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
Changes in Adiposity and Metabolic Measures During Medication Switches to Aripiprazole From Other Atypical Antipsychotics
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole
Changes in Adiposity and Metabolic Measures During Medication Switches to Aripiprazole From Other Atypical Antipsychotics
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia
A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Sheppart Pratt Health System
mi
from
Towson, MD
Double-Blind Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia
A Double-Blind Placebo-Controlled Trial of a Probiotic Supplement to Reduce the Symptoms of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Sheppart Pratt Health System
mi
from
Towson, MD
Click here to add this to my saved trials
Effects of Pentazocine Versus Lorazepam on Manic Symptoms
Effects of Pentazocine Versus Lorazepam on Manic Symptoms
Status: Enrolling
Updated:  12/31/1969
McLean Hospital
mi
from
Belmont, MA
Effects of Pentazocine Versus Lorazepam on Manic Symptoms
Effects of Pentazocine Versus Lorazepam on Manic Symptoms
Status: Enrolling
Updated: 12/31/1969
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
Apostle Clinical Trials, Inc
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
NRC Research Institute
mi
from
Orange, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
NRC Research Institute
mi
from
Orange, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
CNRI - Los Angeles LLC
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
CNRI - San Diego, LLC
mi
from
San Diego, CA
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
CNRI - San Diego, LLC
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
Galiz Research
mi
from
Hialeah, FL
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
Galiz Research
mi
from
Hialeah, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Research, Inc.
mi
from
Hollywood, FL
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Research, Inc.
mi
from
Hollywood, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
CBH Health, LLC
mi
from
Gaithersburg, MD
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
CBH Health, LLC
mi
from
Gaithersburg, MD
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
InSite Clinical Research LLC
mi
from
DeSoto, TX
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
InSite Clinical Research LLC
mi
from
DeSoto, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated:  12/31/1969
Regional Clinical Hospital n.a I.I. Mechnicov
mi
from
Dnipro,
Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intramuscular Injections of Risperidone ISM® in Patients With Acute Exacerbation of Schizophrenia: Open Label Extension (PRISMA-3_OLE)
Status: Enrolling
Updated: 12/31/1969
Regional Clinical Hospital n.a I.I. Mechnicov
mi
from
Dnipro,
Click here to add this to my saved trials
Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia
Status: Enrolling
Updated:  2/27/2006
University of Illinois at Chicago
mi
from
Chicago, IL
Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia
Status: Enrolling
Updated: 2/27/2006
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia
Status: Enrolling
Updated:  2/27/2006
New York Presbyterian Hospital
mi
from
White Plains, NY
Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia
Status: Enrolling
Updated: 2/27/2006
New York Presbyterian Hospital
mi
from
White Plains, NY
Click here to add this to my saved trials
Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
Status: Enrolling
Updated:  10/16/2006
Arthur P. Noyes Research Foundation
mi
from
Norristown, PA
Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia
Status: Enrolling
Updated: 10/16/2006
Arthur P. Noyes Research Foundation
mi
from
Norristown, PA
Click here to add this to my saved trials